<html>
<head>PUBMED IDs for RBM17</head>
<body bgcolor='#C5F0F2'><h1>RBM17</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16061639/'>Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.</a> August 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17676041/'>Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.</a> August 7  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18337722/'>Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.</a> March 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/28007900/'>Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models.</a> December 24  2016<br></body></html>
